Add articles, eBooks or videos to your Library.
You can revisit, watch or read your favorite items later
You can revisit, watch or read your favorite items later
Safety data for Pfizer Inc's experimental respiratory syncytial virus (RSV) vaccine in pregnant women was "generally favorable", the U.S. Food and Drug Administration staff reviewers said on Tuesday.